Veeva Sys Inc Stock Price, News & Analysis

Veeva Systems (NYSE: VEEV) announced that Bristol Myers Squibb (NYSE: BMY) will implement Veeva Vault PromoMats to enhance their promotional material process. This new capability, available in December 2020, allows for automatic generation of submission-ready forms, streamlining the approval process with the U.S. FDA. Vault PromoMats combines digital asset management with regulatory compliance to ensure efficient content distribution. This partnership aims to support Bristol Myers Squibb's needs for faster and compliant content delivery.

Veeva Systems reports that over 75 organizations, including top pharmaceutical companies, are adopting Veeva Vault CTMS to enhance clinical trial efficiency and speed. This modern cloud application is now managing nearly 50,000 clinical trials, facilitating real-time insights and proactive management. The platform integrates with Veeva Vault EDC and includes new capabilities like Vault Payments, allowing for better collaboration and compliance. The focus on streamlining operations aims to mitigate delays and improve overall study execution.

Axsome Therapeutics has partnered with Veeva Systems to enhance its Digital-Centric Commercialization (DCC™) platform, aimed at optimizing marketing for CNS drugs AXS-05 and AXS-07, expected to launch next year. Veeva will provide technology, data, and consulting support, leveraging its Commercial Cloud products to improve physician-patient engagement.

The partnership underscores a significant shift in commercial strategy, focusing on innovative digital tools to streamline drug promotion and improve patient care.

Veeva Systems (NYSE: VEEV) announced the participation of Dr. Francesca Domenech Wuttke and Alessandro de Luca as keynote speakers at the 2020 Veeva Commercial & Medical Summit Online, Europe. The event, featuring over 80 sessions, focuses on digital transformation in life sciences to expedite drug market entry. Notable discussions include insights from Alexion, Boehringer Ingelheim, Lundbeck Italy, and Shionogi on advancing digital strategies. Scheduled for November 17-18, 2020, the summit aims to unite over 3,000 professionals from more than 250 companies in the sector.

Veeva Systems (NYSE: VEEV) announced that Bavarian Nordic is utilizing its Veeva CRM and Veeva Vault PromoMats for a digital product launch across the U.S. and Europe, enhancing their digital engagement capabilities. Bavarian Nordic, focused on vaccines for infectious diseases, chose Veeva to meet aggressive launch timelines and support global growth. This partnership allows for effective HCP interactions through digital channels, ensuring compliance and timely content delivery, further solidifying Veeva's role in driving digital transformation within the life sciences sector.

Veeva Systems has launched MyVeeva for Doctors, a mobile app designed to streamline healthcare professionals' access to key resources from life sciences companies. This solution aims to facilitate connections between healthcare providers and pharmaceutical firms, offering essential services like product samples and copay cards in one place. Early adopters include major companies such as GSK, Pfizer, and Sanofi, with the app currently available in select markets including the US and UK. The initiative is intended to enhance patient care by improving the efficiency of healthcare professionals.

Veeva Systems (NYSE: VEEV) has launched MyVeeva for Doctors, a mobile app aimed at enhancing healthcare professionals' access to resources from pharmaceutical and biotech companies. This initiative aims to streamline interactions between healthcare providers (HCPs) and life sciences, allowing HCPs to easily connect with key contacts and access information. Initial partnerships include major companies like Boehringer Ingelheim, GSK, and Pfizer. The app is currently available in select markets including the U.S. and U.K., with plans for expansion in 2021.